Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
02/2014
02/27/2014US20140056847 Inhibitors of serine proteases
02/27/2014US20140056820 Transport agents for crossing the blood-brain and into brain cancer cells and methods of use thereof
02/27/2014US20140056815 Methods to regulate polarization and enhance function of cells
02/27/2014US20140056809 Treatment and diagnosis of macrophage mediated disease
02/26/2014EP2700404A1 Antcin derivatives in combination with an anti-cancer drug in treatment and/or prevention of tumors
02/26/2014EP2699251A1 Infant formula for use in the prevention of cardiovascular diseases
02/26/2014EP2699233A1 A method for the treatment of a solid tumour
02/26/2014CN103608006A New combination comprising N-acetyl-L-cysteine and its use
02/26/2014CN103602724A Methods for determining hepatocellular carcinoma subtype and detecting hepatic cancer stem cells
02/26/2014CN103599547A Nitric oxide donor type non-steroidal anti-inflammatory drug beta-cyclodextrin or beta-cyclodextrin derivative inclusion compound as well as preparation method and application thereof
02/26/2014CN103599540A Pharmaceutical composition containing glinides and vitamin B, and use of pharmaceutical composition
02/26/2014CN103599539A Combination therapy comprising SGLT inhibitor and DPP4 inhibitor
02/26/2014CN103599538A Preparation method of polymer nanoparticles containing antiretroviral drugs
02/26/2014CN103599537A Pharmaceutical composition of calcium channel blocker/thiazide diuretic/5-methyltetrahydrofolate
02/26/2014CN103599536A Use of 3-alpha-androstanediol in the treatment of sexual dysfunction, optionally in combination with a 5-HT1A agonist
02/26/2014CN103599124A Compositions containing CDP-choline, and methods of use thereof
02/26/2014CN102813753B Composition containing Cistanche deserticola or Herba Cynomorii and combination of chrysanthemum, taurine, lycopene, xanthophyll and beta-carotene
02/26/2014CN102657597B Biodegradable super-molecular hydrogel loaded with antitumor medicament and preparation method thereof
02/26/2014CN101837125B Method of regulating phosphorylation of PTH protein and antiviral agents comprising SR protein activity regulator as the active ingredient
02/26/2014CN101180018B Transdermal method and patch for nausea
02/25/2014US8658610 Replication-competent anti-cancer vectors
02/25/2014US8658607 Immunostimulatory G, U-containing oligoribonucleotides
02/25/2014US8658433 Dye compounds as photoactive agents
02/25/2014US8658373 Method of screening for an agent for treating arthritis and promoting growth of articular chondrocytes
02/25/2014US8658206 Compositions comprising strontium and vitamin D and uses thereof
02/25/2014US8658158 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus
02/20/2014WO2014028675A1 Use of aminoindane compounds in treating overactive bladder and interstitial cystitis
02/20/2014WO2014028566A1 Combination of pi3k inhibitor and c-met inhibitor
02/20/2014WO2014028560A2 T-cell redirecting bispecific antibodies for treatment of disease
02/20/2014WO2014028509A2 Thrombopoietin mimetics for the treatment of radiation or chemical induced bone marrow injury
02/20/2014WO2014028241A1 Novel cell compositions and methods
02/20/2014WO2014004674A3 Combination treatment of abt-450 and ritonavir and e.g. abt-072 and/or abt-333|for use in treating hcv
02/20/2014WO2013173417A3 Glucokinase activator compositions for the treatment of diabetes
02/20/2014US20140052175 High strength suture with absorbable core and suture anchor combination
02/20/2014US20140051760 Hybrid Molecule Having Mixed Retinoic Acid Receptor Agonism and Histone Deacetylase Inhibitory Properties
02/20/2014US20140051758 High purity 2-[4-(3- or 2-fluorobenzyloxy)benzylamino] propanamides and methods of use thereof
02/20/2014US20140051749 Solid forms of an antiviral compound
02/20/2014US20140051745 Micro-rnas of the mir-15 family modulate cardiomyocyte survival and cardiac repair
02/20/2014US20140051744 Markers For Assessing the Susceptibility of Cancer to Survivin-Targeting miRNA Treatment
02/20/2014US20140051742 Lipophilic Curcumin Analogs And Methods Of Inhibiting HIV-1, Treating Latent HIV In The Brain, And Preventing HIV-Mediated Cognitive Decline And HIV Dementia
02/20/2014US20140051740 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
02/20/2014US20140051738 Oxymetazoline For The Treatment Of Ano-Rectal Disorders
02/20/2014US20140051737 Methods for the treatment and diagnostic of pulmonary arterial hypertension
02/20/2014US20140051731 Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
02/20/2014US20140051730 Therapeutic use of dimiracetam to prevent the hand and foot syndrome caused by sorafenib
02/20/2014US20140051716 Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitors
02/20/2014US20140051714 Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
02/20/2014US20140051708 Pyrazolyl-pyrimidine derivatives as kinase inhibitors
02/20/2014US20140051704 Hypotensive Lipid And Timolol Compositions And Methods Of Using Same
02/20/2014US20140051697 Compounds for treating respiratory syncytial virus infections
02/20/2014US20140051692 Inhibitors of Human Immunodeficiency Virus Replication
02/20/2014US20140051677 Novel compound useful for the treatment of degenerative and inflammatory diseases
02/20/2014US20140051676 Triazine-oxadiazoles
02/20/2014US20140051674 New compounds
02/20/2014US20140051672 1,4-disubstituted pyridazine analogs there of and methods for treating smn-deficiency-related conditions
02/20/2014US20140051670 Compositions Containing Moxifloxacin for Treating Otic Infections
02/20/2014US20140051666 Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
02/20/2014US20140051664 Combination therapy of hsp90 inhibitory compounds with radiotherapy
02/20/2014US20140051662 Treatment of multiple myeloma with masitinib
02/20/2014US20140051656 Antiviral compounds
02/20/2014US20140051655 Methods of treating inflammatory and autoimmune diseases with alpha-4 inhibitory compounds
02/20/2014US20140051648 Inhibitor of Sodium-Dependent Glucose Transport Protein and Preparation Method Therefor and Use Thereof
02/20/2014US20140051641 Compounds for enzyme inhibition
02/20/2014US20140051634 Pharmaceutical combined preparation containing a therapeutic protein
02/20/2014US20140051629 Modulators of the gpr119 receptor and the treatment of disorders related thereto
02/20/2014US20140050808 Stabilized formulation comprising omega-3 fatty acids and use of the fatty acids for skin care and/or wound care
02/20/2014US20140050807 Compositions containing omega-3 oil with an anti-inflammatory agent and uses thereof
02/20/2014US20140050803 Compositions and methods for treatment of melanoma
02/20/2014US20140050793 Novel Compositions for Inhibiting Virus Entry and Promoting Virolysis, and Methods Thereof
02/20/2014US20140050788 Micronized placental tissue compositions and methods of making and using the same
02/20/2014US20140050783 Methods and compositions for sleep disorders and other disorders
02/20/2014US20140050781 Use of AGR3 for Treating Cancer
02/20/2014US20140050780 Liposomal formulation of nonglycosidic ceramides and uses thereof
02/20/2014US20140050747 Trace Elements
02/20/2014US20140050746 Auristatin drug linker conjugates
02/20/2014US20140050739 Local complement inhibition for treatment of complement-mediated disorders
02/20/2014US20140050737 Compounds for enzyme inhibition
02/20/2014US20140050735 Treatment of fistulizing chrohn's disease
02/20/2014US20140050728 Methods and compositions for inhibiting cyclophilin d for the treatment and prevention of obesity and kidney indications
02/20/2014US20140050724 Compositions and Methods
02/20/2014US20140050721 Antineoplastic Combinations with mTOR Inhibitor, Trastuzumab and/or HKI-272
02/20/2014US20140050718 Methods and Compositions for Enhancing Intranasal Delivery of Therapeutic Agents
02/20/2014US20140050717 Methods for Treating Bleeding Disorders
02/20/2014US20140050714 Use of hsp70 as a regulator of enzymatic activity
02/20/2014US20140050712 Disorders implicating pufa oxidation
02/20/2014US20140050699 Heterocyclic inhibitors of glutaminase
02/20/2014US20140050697 Analysis of hcv genotypes
02/20/2014US20140050696 Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use
02/20/2014US20140050695 Hepatitis C Virus Inhibitors
02/20/2014US20140050694 Method of Treating Transplant Rejection and Autoimmune Diseases
02/20/2014US20140050675 Antioxidant compositions for soft oral tissue and methods of formulation and use thereof
02/20/2014US20140050661 Novel anti-cxcr4 antibodies and their use for the treatment of cancer
02/20/2014US20140050660 T-Cell Redirecting Bispecific Antibodies for Treatment of Disease
02/20/2014CA2874864A1 T-cell redirecting bispecific antibodies for treatment of disease
02/19/2014EP2698637A1 Marker for determination of sensitivity to anti-cancer agent
02/19/2014EP2698167A2 Dosage form of an estriol and glatiramer acetate polymer-1 for the treatment of multiple sclerosis
02/19/2014EP2698153A1 Prevention and treatment of oxidative stress disorders by compounds which elevate intracellular levels of glutathione or phase II detoxification enzymes
02/19/2014EP2698150A1 Oral solid preparation of compound antituberculosis drug and preparation method thereof
02/19/2014EP2697200A1 Substituted bicyclic methyl azetidines as sphingosine-1 phosphate receptors modulators
02/19/2014EP2696875A1 Methods for treating bacterial infection
1 ... 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 ... 1151